Neumora Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neumora therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neumora Therapeutics Today - Breaking & Trending Today

Avidity Partners Management LP Purchases 190,632 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA)

Avidity Partners Management LP lifted its position in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,990,632 shares of the company’s stock after purchasing an additional 190,632 shares during the quarter. Avidity Partners […] ....

New York , United States , William Blair , Jpmorgan Chase Co , Sg Americas Securities , Neumora Therapeutics Inc , Tower Research Capital , York State Common Retirement Fund , Securities Exchange Commission , Royal Bank , Avidity Partners Management , Neumora Therapeutics , Free Report , Partners Management , Research Capital , New York State Common Retirement Fund , Therapeutics Trading Down , Get Free Report , Visit Holdingschannel , Neumora Therapeutics Daily ,

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month […] ....

William Blair , Royal Bank , Jpmorgan Chase Co , Kennedy Capital Management , Nan Fung Group Holdings Ltd , Neumora Therapeutics Company Profile , Artal Group , Neumora Therapeutics Inc , Pricet Rowe Associates Inc , Neumora Therapeutics , Get Free Report , Therapeutics Trading Down , Capital Management , Get Free , Neumora Therapeutics Daily ,

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The […] ....

New York , United States , William Blair , Neumora Therapeutics Inc , York State Common Retirement Fund , Royal Bank , Jpmorgan Chase Co , Citigroup Inc , Neumora Therapeutics , Get Free Report , Marketbeat Ratings , Amalgamated Bank , Get Free , Neumora Therapeutics Daily ,

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression

Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Robert Lenz , Dan Iosifescu , Helen Rubinstein , Neumora Therapeutics Inc , Grossman School Of Medicine , Exchange Commission , Department Of Psychiatry , Therapeutics Announces Initiation , Depression Rating , Neumora Therapeutics , Private Securities Litigation Reform Act , Quarterly Report ,